Sekisui Diagnostics, LLC Enters Strategic Partnership with Qualigen Inc.

– Sekisui Diagnostics becomes exclusive commercial partner for the Qualigen FastPack® IP System in the U.S. and international markets

– Sekisui Diagnostics to expand point of care testing portfolio with the FastPack® IP System from Qualigen Inc.

– Qualigen expands their commercial reach through relationship with Sekisui Diagnostics

LEXINGTON, Massachusetts, May 3, 2016 /PRNewswire/ — Today, Sekisui Diagnostics and Qualigen Inc. announce a new strategic partnership, encompassing both current business and future collaboration opportunities. Effective immediately Sekisui Diagnostics will assume commercial activities and distribution management for the FastPack® IP System and associated products in the U.S. and international markets.

Sekisui Diagnostics Logo.

Photo – http://photos.prnewswire.com/prnh/20160502/362638
Logo – http://photos.prnewswire.com/prnh/20150723/240846LOGO
Logo – http://photos.prnewswire.com/prnh/20160502/362639LOGO

The FastPack® IP System is an established, point of care immunoassay system designed to enable physician office laboratories (POLs) to offer key quantitative test results where there is immediate clinical value. The test menu includes Vitamin D, Testosterone, TSH, Free T4, PSA, and hCG.

“Sekisui Diagnostics is delighted to announce our new relationship with Qualigen which will add to our existing rapid test portfolio in POL markets,” said Robert Schruender, President and COO of Sekisui Diagnostics. “This system is highly compatible with our business channels and relationship with distributors, especially McKesson.  It also offers the potential to strengthen our portfolio in the mid-to-long term.”

“Qualigen is excited to partner with Sekisui Diagnostics in expanding commercial opportunities for the FastPack® IP System, which is well proven in the market”, said Paul Rosinack, President and CEO of Qualigen. “Our technology and platform creates synergies with their portfolio, which will add another dimension to our long term growth.”

About Sekisui Diagnostics:

Sekisui Diagnostics is a global diagnostics company committed to improving patient’s lives by providing innovative medical diagnostics to physicians and laboratories through a global commercial network.  Product lines include clinical chemistry and coagulation systems, reagents, infectious disease testing and rapid test kits, as well as enzymes and specialty bio-chemicals.

About Qualigen:

Qualigen Incorporated is a leader in the development, manufacturing and marketing of innovative medical diagnostic products that provide rapid and accurate information directly to physicians and the patients who trust them.  The FastPack® IP System is a state of the art, near-patient blood analyzer that provides quantitative immunoassay results, at the push of a button, for important biomarkers in the areas of cancer, metabolic disorders, hormone regulation and pregnancy management.

Releated

Syntonic announces international launch of the Freeway Roaming Service™ for mobile carriers

New service enables operators to accelerate growth in international roaming ARPUs by participating in the US$676 billion generated by online travel services SEATTLE, June 06, 2018 (GLOBE NEWSWIRE) — Syntonic, a mobile platform and services provider, today announced the commercial launch of its international Freeway Roaming Service for mobile carriers. Syntonic’s Freeway Roaming Service enables mobile […]

KT poursuit son développement en Afrique suite au succès de son projet LTE au Rwanda

– LTE présente le projet LTE d’envergure nationale mis en place au Rwanda lors de la conférence KOAFEC 2018 – – KT s’engage dans le développement la croissance économique basée sur les TIC en Afrique – SÉOUL, Corée du Sud, 29 mai 2018 /PRNewswire/ – KT Corp. (KRX : 030200 ; NYSE : KT), la plus grande société de télécommunications de Corée, […]